Teva.com

Site Inspections

Overview & More informations

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel. It is the world's largest generic drug manufacturer, and also develops, produces, and markets a portfolio of branded and specialty pharmaceuticals. The company operates in over 60 countries and employs approximately 45,000 people.

Teva was founded in 1901 as a small pharmacy in Jerusalem. The company began producing generic drugs in the 1970s, and by the 1990s had become one of the world's leading generic drug manufacturers. In 2005, Teva acquired the branded drug company Ivax Pharmaceuticals, and in 2008 it acquired the specialty drug company Cephalon.

Today, Teva is a global pharmaceutical company with a diverse portfolio of products. The company's generic drugs account for approximately 70% of its revenue, while its branded and specialty pharmaceuticals account for the remaining 30%. Teva's products are used to treat a wide range of conditions, including cancer, cardiovascular disease, diabetes, and multiple sclerosis.

Teva has been the subject of controversy in recent years. In 2016, the company was sued by the United States Department of Justice for allegedly paying bribes to doctors in order to promote its drugs. The company also faces lawsuits from consumers who allege that its drugs caused them harm.

Despite these challenges, Teva remains a global leader in the pharmaceutical industry. The company's strong generics business and its growing portfolio of branded and specialty pharmaceuticals position it well for continued growth in the future.

Here are some more key facts about Teva Pharmaceutical Industries Ltd.:

* The company's revenue in 2021 was $16.1 billion.
* The company's net income in 2021 was $3.6 billion.
* The company's market capitalization as of August 8, 2023, is $23.5 billion.
* The company's stock price as of August 8, 2023, is $11.09.

Domains Expiration Date Updated